Pfizer Alzheimer’s drug fails in study (USA Today)
Thursday, March 4th, 2010A promising Alzheimer’s disease drug Pfizer Inc. and a partner are developing failed to work in a late-stage study, a startling disappointment after the potential blockbuster kept symptoms from worsening for a year in a prior test.